Bardin Hill Management Partners’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bardin Hill Management Partners’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-195,192	Closed	-$3.43M	–	109
2021 Q3	$3.43M	Buy	+195,192	New	+$2.28M	0.55%	36

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Bardin Hill Management Partners's TRIL Position: Q4 2021 in Review

Bardin Hill Management Partners sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 195,192 shares — an estimated $3.43M sold.

Bardin Hill Management Partners first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $3.43M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Bardin Hill Management Partners reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Bardin Hill Management Partners sold 195,192 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $3.43M.
Bardin Hill Management Partners first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Bardin Hill Management Partners's Trillium Therapeutics Inc. position peaked at $3.43M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Bardin Hill Management Partners's 13F filing for Q4 2021, filed 14 Feb 2022.